ES2317223T3 - Derivados de tioamida como moduladores del receptor de progesterona. - Google Patents

Derivados de tioamida como moduladores del receptor de progesterona. Download PDF

Info

Publication number
ES2317223T3
ES2317223T3 ES05735464T ES05735464T ES2317223T3 ES 2317223 T3 ES2317223 T3 ES 2317223T3 ES 05735464 T ES05735464 T ES 05735464T ES 05735464 T ES05735464 T ES 05735464T ES 2317223 T3 ES2317223 T3 ES 2317223T3
Authority
ES
Spain
Prior art keywords
compound
formula
alkyl
substituted
quad
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05735464T
Other languages
English (en)
Spanish (es)
Inventor
Bogdan Kazimierz Wilk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Application granted granted Critical
Publication of ES2317223T3 publication Critical patent/ES2317223T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Ink Jet (AREA)
ES05735464T 2004-04-08 2005-04-07 Derivados de tioamida como moduladores del receptor de progesterona. Expired - Lifetime ES2317223T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56056904P 2004-04-08 2004-04-08
US560569P 2004-04-08

Publications (1)

Publication Number Publication Date
ES2317223T3 true ES2317223T3 (es) 2009-04-16

Family

ID=34965700

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05735464T Expired - Lifetime ES2317223T3 (es) 2004-04-08 2005-04-07 Derivados de tioamida como moduladores del receptor de progesterona.

Country Status (14)

Country Link
US (4) US7358246B2 (cg-RX-API-DMAC7.html)
EP (1) EP1732921B1 (cg-RX-API-DMAC7.html)
JP (1) JP4869221B2 (cg-RX-API-DMAC7.html)
CN (1) CN100522960C (cg-RX-API-DMAC7.html)
AT (1) ATE413398T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005233591B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0509209A (cg-RX-API-DMAC7.html)
CA (1) CA2561014C (cg-RX-API-DMAC7.html)
DE (1) DE602005010840D1 (cg-RX-API-DMAC7.html)
DK (1) DK1732921T3 (cg-RX-API-DMAC7.html)
ES (1) ES2317223T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA06011696A (cg-RX-API-DMAC7.html)
PL (1) PL1732921T3 (cg-RX-API-DMAC7.html)
WO (1) WO2005100346A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4950027B2 (ja) * 2004-04-08 2012-06-13 ワイス・エルエルシー チオアミド不純物を最小限に抑えるための方法
EP1732921B1 (en) * 2004-04-08 2008-11-05 Wyeth Thioamide derivatives as progesterone receptor modulators
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
US20070093548A1 (en) * 2005-10-25 2007-04-26 Wyeth Use of progesterone receptor modulators
US7618989B2 (en) * 2006-08-15 2009-11-17 Wyeth Tricyclic oxazolidone derivatives useful as PR modulators
US20090170823A1 (en) * 2007-12-20 2009-07-02 Duramed Pharmaceuticals, Inc. Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception
CN107281215A (zh) * 2016-04-01 2017-10-24 复旦大学附属妇产科医院 硫化氢供体硫氢化钠在制药中的用途

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4295987A (en) 1979-12-26 1981-10-20 The Procter & Gamble Company Cross-linked sodium polyacrylate absorbent
US4959217A (en) 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
AU608891B2 (en) 1987-09-24 1991-04-18 Merck & Co., Inc. Solubility modulated drug delivery device
US5273752A (en) 1989-07-18 1993-12-28 Alza Corporation Controlled release dispenser comprising beneficial agent
US5124455A (en) 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
US5459151A (en) 1993-04-30 1995-10-17 American Home Products Corporation N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
US5854388A (en) 1993-06-24 1998-12-29 Washington State University Research Foundation Angiotensin IV peptides and receptor
US5817343A (en) 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
US5756127A (en) 1996-10-29 1998-05-26 Wright Medical Technology, Inc. Implantable bioresorbable string of calcium sulfate beads
FI971385A0 (fi) 1997-04-04 1997-04-04 Bioxid Oy Biokompatibel komposition, metoder foer dess framstaellning samt anvaendning daerav
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
AU767762B2 (en) * 1999-05-04 2003-11-20 Wyeth Thio-oxindole derivatives
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6355648B1 (en) * 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
HUP0202936A3 (en) 1999-08-10 2003-11-28 Smithkline Beecham Corp 1,4-substituted 4,4-diaryl cyclohexanes, pharmaceutical compositions containing them and their use
US6258833B1 (en) 1999-12-23 2001-07-10 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
JP4716547B2 (ja) * 2000-08-10 2011-07-06 住友精化株式会社 2−フェニルチアゾール類の製造方法
US20030225273A1 (en) * 2002-03-21 2003-12-04 Michaelides Michael R. Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
CA2485641C (en) * 2002-06-06 2010-12-14 Eisai Co., Ltd. Novel condensed imidazole derivatives
MXPA04012418A (es) 2002-06-25 2005-04-19 Wyeth Corp Uso de derivados de tio-oxindol en tratamiento de trastornos de la piel.
EP1531824A4 (en) 2002-06-25 2005-09-21 Wyeth Corp CYCLOTHIOCARBAMATE DERIVATIVES AS PR-MODULATORS AND THEIR USE IN THE TREATMENT OF SKIN DISEASES
JP2005535623A (ja) * 2002-06-25 2005-11-24 ワイス ホルモン関連症状の治療における、チオ−オキシインドール誘導体の使用
AU2003247608A1 (en) 2002-06-25 2004-01-06 Wyeth Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
JP4950027B2 (ja) * 2004-04-08 2012-06-13 ワイス・エルエルシー チオアミド不純物を最小限に抑えるための方法
EP1732921B1 (en) 2004-04-08 2008-11-05 Wyeth Thioamide derivatives as progesterone receptor modulators
JP4906711B2 (ja) 2004-04-08 2012-03-28 ワイス・エルエルシー 3−シクロペンチルオキシ−4−メトキシベンズアルデヒドの製造方法
BRPI0510260A (pt) 2004-04-27 2007-10-23 Wyeth Corp método para purificar um composto, e, kit farmacêutico

Also Published As

Publication number Publication date
US7659265B2 (en) 2010-02-09
PL1732921T3 (pl) 2009-04-30
BRPI0509209A (pt) 2007-08-28
DE602005010840D1 (de) 2008-12-18
EP1732921A1 (en) 2006-12-20
JP4869221B2 (ja) 2012-02-08
EP1732921B1 (en) 2008-11-05
US20080167299A1 (en) 2008-07-10
CN100522960C (zh) 2009-08-05
ATE413398T1 (de) 2008-11-15
CN1938299A (zh) 2007-03-28
US7358246B2 (en) 2008-04-15
WO2005100346A1 (en) 2005-10-27
US8168672B2 (en) 2012-05-01
US20050227971A1 (en) 2005-10-13
US20090143345A1 (en) 2009-06-04
DK1732921T3 (da) 2009-02-23
AU2005233591B2 (en) 2011-10-27
JP2007532564A (ja) 2007-11-15
MXPA06011696A (es) 2006-12-14
CA2561014C (en) 2013-09-10
CA2561014A1 (en) 2005-10-27
US7511071B2 (en) 2009-03-31
US20100197645A1 (en) 2010-08-05
AU2005233591A1 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
ES2256008T3 (es) Cianopirroles como agonistas del receptor de la progesterona.
US7538107B2 (en) Oxazinan-2-one derivatives useful as PR modulators
US7649007B2 (en) Oxazolidine derivatives as PR modulators
KR101126895B1 (ko) 프로게스테론 수용체의 인돌 술폰아미드 조절제
JP5039541B2 (ja) プロゲステロン受容体調節剤の精製
US20060030615A1 (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
US20080114050A1 (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
US20080119537A1 (en) 5-Aryl indan-1 one and analogs useful as progesterone receptor modulators
US8168672B2 (en) Thioamide derivatives as progesterone receptor modulators
US20080045560A1 (en) Pyrrolidine and related derivatives useful as PR modulators
KR20050013247A (ko) 호르몬-관련 병리상태를 치료하기 위한사이클로티오카바메이트 유도체의 용도
WO2008021338A2 (en) Tricyclic oxazolidone derivatives useful as pr modulators
US20070066628A1 (en) 5-Aryl-indan-1-ol and analogs useful as progesterone receptor modulators
CA2679380A1 (en) Sulfonylated heterocycles useful for modulation of the progesterone receptor
US7652018B2 (en) Imidazolidin-2-one derivatives useful as PR modulators